Displaying items by tag: division of pulmonary allergy and critical care medicine
A new drug that improves lung function for some patients with cystic fibrosis may also help treat smokers with the incurable lung disease COPD.
The Program in Environmental and Translational Medicine combines clinical care with research to prevent, treat diseases caused from air pollution, water contamination, other causes.
UAB doctors can now employ a new procedure, using thermal energy, to open constricted airways in patients whose severe asthma is not controlled by medication.
UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.
A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.
An antibiotic can help reduce acute COPD attacks and improve quality of life, a new study shows.
UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.